Phase 2 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For Parts 1 and 2 of the trial:
- You are between 18 and 65 years old
- You are generally in good health with no major medical conditions
- You are willing and able to attend all study appointments and follow all study requirements, including a procedure to collect fluid from around your spine (confirm with trial site)
- You are able to read and sign a consent form agreeing to take part
For Part 3 of the trial:
- You are between 18 and 60 years old
- You are generally in good health with no major medical conditions
- You have been diagnosed with Multiple Sclerosis (MS) before the study begins, confirmed using specific medical guidelines from 2017
- You are willing and able to attend all study appointments and follow all study requirements, including a procedure to collect fluid from around your spine (confirm with trial site)
- You are able to read and sign a consent form agreeing to take part
Who may not be able to join:
- You have a significant ongoing health condition or serious illness
- You have any physical or mental health condition that would prevent you from completing the study
- You have a known history of illegal drug use, drug abuse, heavy alcohol use, alcoholism, or have smoked or used any nicotine products in the 7 days before your first dose
- You have a history of severe allergic reactions or serious sensitivities to substances
- You have donated blood or lost a significant amount of blood (one unit or more) within the 4 weeks before receiving the study treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +61 (0) 422 447 902
Australian sites
+61 (0)8 7088 7900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence, nature, and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs) of VT7208 in healthy volunteers and patients with MS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.